Joe Rogan Experience #1234 - David Sinclair

Joe Rogan Experience #1234 - David Sinclair

The Joe Rogan ExperienceJan 29, 20192h 21m

Joe Rogan (host), David Sinclair (guest)

Treating aging as a disease and the biology of longevitySinclair’s personal anti-aging regimen (NMN, resveratrol, metformin, lifestyle)Key longevity pathways: sirtuins, AMPK, mTOR and hormesisDiet, fasting, protein intake, and exercise for lifespan and healthspanEpigenetics, the ‘aging clock,’ and reprogramming cells to a younger stateEmerging therapies: NAD boosters, gene therapies, and glaucoma trialsEthics, economics, and societal impact of life-extension technologies

In this episode of The Joe Rogan Experience, featuring Joe Rogan and David Sinclair, Joe Rogan Experience #1234 - David Sinclair explores harvard longevity scientist reveals real-world strategies to slow aging Joe Rogan interviews Harvard geneticist David Sinclair about emerging science that treats aging as a disease-like process that can be slowed and potentially reversed. Sinclair explains how pathways like sirtuins, AMPK, and mTOR respond to stressors such as fasting, exercise, heat, and cold—and how certain molecules (like NMN, resveratrol, and metformin) can pharmacologically tap into those systems. They cover Sinclair’s personal regimen, the ethics and economics of longevity drugs, and how epigenetic damage—not just DNA mutations—may underlie aging. The conversation ranges from diet, exercise, and blood testing to CRISPR, designer babies, Lyme disease diagnostics, and future therapies that may restore vision and rejuvenate tissues.

Harvard longevity scientist reveals real-world strategies to slow aging

Joe Rogan interviews Harvard geneticist David Sinclair about emerging science that treats aging as a disease-like process that can be slowed and potentially reversed. Sinclair explains how pathways like sirtuins, AMPK, and mTOR respond to stressors such as fasting, exercise, heat, and cold—and how certain molecules (like NMN, resveratrol, and metformin) can pharmacologically tap into those systems. They cover Sinclair’s personal regimen, the ethics and economics of longevity drugs, and how epigenetic damage—not just DNA mutations—may underlie aging. The conversation ranges from diet, exercise, and blood testing to CRISPR, designer babies, Lyme disease diagnostics, and future therapies that may restore vision and rejuvenate tissues.

Key Takeaways

Intermittent fasting and mild stressors activate built-in longevity pathways.

Periods of hunger, intense but not excessive exercise, sauna/cold exposure, and other hormetic stressors switch on protective systems (like sirtuins and AMPK) that repair damage and extend healthspan in animals.

Get the full analysis with uListen AI

Boosting NAD levels with precursors like NMN may restore youthful cellular function.

NAD declines sharply with age; precursors such as NMN (and NR) raise NAD back toward youthful levels in animals, improving endurance, blood vessel function, and overall metabolic health, with human trials underway.

Get the full analysis with uListen AI

Certain drugs with long safety records may slow age-related disease risk.

Metformin, a common diabetes drug, is associated in large human datasets with lower rates of cancer, heart disease, frailty, and possibly longer lifespan, leading many aging researchers (including Sinclair) to take it off-label.

Get the full analysis with uListen AI

Lower protein and amino acid intake—especially from red meat—may favor longevity.

High intake of certain amino acids and red meat activates mTOR and produces TMAO, both linked to shorter lifespan and heart disease in animal and epidemiological studies; shifting toward plant-based, fish, and modest white meat may help.

Get the full analysis with uListen AI

Aging may be driven more by epigenetic ‘noise’ than by DNA mutations alone.

Sinclair posits that repeated DNA damage and repair scratch the epigenetic ‘reader’ system, causing cells to misread genes over time; resetting that epigenetic program in animals can make tissues functionally younger again.

Get the full analysis with uListen AI

Regular, data-driven monitoring can personalize and optimize longevity strategies.

Frequent blood work, biological age tests, and tracking tools (e. ...

Get the full analysis with uListen AI

Next-generation therapies may rejuvenate specific organs, starting with the eye.

Sinclair’s team has used gene therapy to reprogram retinal cells in mice, restoring vision after optic nerve damage, glaucoma, and age-related decline, with human glaucoma trials targeted around 2020 and broader applications envisioned later.

Get the full analysis with uListen AI

Lifestyle still matters, even with powerful molecules.

In animal studies, compounds like resveratrol and NMN work best when layered on top of calorie control and exercise; they enhance, rather than replace, healthy habits.

Get the full analysis with uListen AI

Notable Quotes

“I absolutely think aging should be classified as a disease.”

David Sinclair

“We can trick the body into being hungry and in adversity, even if you’re eating a lot or you’re not exercising.”

David Sinclair

“What I think is causing aging is not the loss of the digital information but it’s the reader… like a DVD that’s scratched.”

David Sinclair

“If I died from heart disease tomorrow, that’d be a bad look.”

David Sinclair

“We’re so pathetic as a species, our answer would be, ‘You mean that’s a thing? You can do something about that?’”

Joe Rogan

Questions Answered in This Episode

How strong is the current human evidence that NMN or NR truly improve healthspan, beyond raising NAD levels in blood tests?

Joe Rogan interviews Harvard geneticist David Sinclair about emerging science that treats aging as a disease-like process that can be slowed and potentially reversed. ...

Get the full analysis with uListen AI

If metformin and rapamycin affect similar aging pathways, how do their risk–benefit profiles compare for otherwise healthy people?

Get the full analysis with uListen AI

What are the biggest scientific and safety hurdles to using epigenetic reprogramming in whole humans rather than just localized tissues like the eye?

Get the full analysis with uListen AI

How should average people balance the trade-off between maximizing current performance (e.g., high protein, BCAAs) and maximizing long-term longevity?

Get the full analysis with uListen AI

What ethical and regulatory frameworks are needed to govern gene editing, designer babies, and life-extension therapies so they don’t widen inequality or trigger backlash?

Get the full analysis with uListen AI

Transcript Preview

Joe Rogan

Here we go. Five, four, three, two, one. David.

David Sinclair

Joe.

Joe Rogan

How are you, sir?

David Sinclair

Great. Thanks.

Joe Rogan

Thanks for being here, man. I appreciate it.

David Sinclair

Hey, thanks for having me on.

Joe Rogan

Really looking forward to talking to you. Very much so.

David Sinclair

Well...

Joe Rogan

Um, this is a fascinating subject for me. Anti-aging. The idea that you'll be able to stop aging, or even possibly pull it back, or at v- very least slow it down. What do you think?

David Sinclair

I think that's all on the table. We've been doing this for years in the lab. Now we've just got to figure out how to do it in people.

Joe Rogan

When I talk to someone like you as an actual research scientist in this stuff, I always want to know, what are you doing to yourself?

David Sinclair

Ah. How long have you got? (laughs)

Joe Rogan

(laughs) Like, what do you do on a daily basis?

David Sinclair

What do I do? I'm-

Joe Rogan

First of all, are you 100 years old?

David Sinclair

Uh, getting there.

Joe Rogan

How old are you?

David Sinclair

Uh, turning 50. So...

Joe Rogan

Oh, you're turning 50? Hmm.

David Sinclair

Yeah.

Joe Rogan

I wouldn't have thought you were 50. I would've figured you were for about 41, 42.

David Sinclair

Oh, that's kind of you. Um-

Joe Rogan

Hmm.

David Sinclair

Well, my brother's the negative control and he's, he's, uh...

Joe Rogan

Does he look like shit?

David Sinclair

Well, I can't say that, but, uh...

Joe Rogan

(laughs)

David Sinclair

People say that he doesn't look as young as me and he's about three and a half years younger.

Joe Rogan

Oh. So what are you doing personally?

David Sinclair

Uh, well, you know, most of the time, I'm in the lab and trying to run a bunch of companies to make these drugs a reality. Uh, but daily, you know, I try to keep a healthy weight. I do intermittent fasting, uh, which is pretty easy, 'cause I'm so busy, I forget to eat.

Joe Rogan

How many hours do you give yourself per night?

David Sinclair

Uh, well, I suffer from, uh, late night snacking, but I try to skip breakfast and, and even skip lunch if I'm busy. So I'm a night eater. Um, but that seemed to be good, 'cause a, a study came out about a couple of weeks ago, at least in mice, that it's not what you eat, it's when you eat that's most important for longevity.

Joe Rogan

Really?

David Sinclair

Yeah.

Joe Rogan

And when, when being when? Like what's best?

David Sinclair

Well, I, it doesn't actually matter, uh, if you eat a lot in the morning or a lot at night. I like nighttime eating. But you need a period during the day, at least if you're a mouse, probably if you're a human, where you're hungry. Um, and that puts your body in a defensive mode. And these, these are the things that we've been studying in my lab for the last 20 years. What are the processes that diet and exercise do for us that keep us healthy, and why does calorie restriction and intermittent fasting make animals live so much longer? And we think we've figured out a large part of how that works, and now we're mimicking that with molecules.

Install uListen to search the full transcript and get AI-powered insights

Get Full Transcript

Get more from every podcast

AI summaries, searchable transcripts, and fact-checking. Free forever.

Add to Chrome